Dr. Felix R. Ehrat will become the new General Counsel of Novartis
The partnership of Bär & Karrer is pleased and honored to announce that Dr. Felix R. Ehrat will become the new General Counsel and permanent attendee of the Executive Committee of Novartis effective 1st October 2011. He will directly report to Joseph Jimenez, CEO of Novartis. Felix R. Ehrat has served as Managing Partner of Bär & Karrer since 2000, as its Senior Partner since 2003 and as its Executive Chairman since 2007. As leading practitioner in the fields of corporate and M&A law, corporate governance, banking law, arbitration and as a leader of the firm, Felix R. Ehrat has made significant contributions to the long time development of Bär & Karrer during his career of now more than 24 years.
Felix R. Ehrat will be succeeded by Daniel Hochstrasser as Senior Partner and Executive Chairman. Daniel Hochstrasser is a leading litigator and arbitrator in Switzerland. On behalf of the partnership, Daniel Hochstrasser states: "Felix' departure constitutes a significant loss for our firm but is also a tribute to the quality of our firm and our work. His contribution to the successful development of Bär & Karrer in the last decades has been invaluable and he was the face of our firm in Switzerland and abroad. We will miss him. At the same time, we are proud of his new position in one of the largest global companies and wish him all the best. My intention is to lead the firm in the spirit of Felix; we remain committed to be a best-in-class service provider to all our current and future clients and an employer where top legal talent enjoys to work."